| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Net sales | ||||||
1,476,353 | 1,578,203 | 1,328,297 | - | - | ||
Cost of sales | ||||||
1,086,644 | 1,148,232 | 950,701 | - | - | ||
Gross profit | ||||||
389,708 | 429,971 | 377,596 | - | - | ||
Selling, general and administrative expenses | ||||||
206,886 | 231,918 | 207,493 | - | - | ||
Research and development costs | ||||||
19,874 | 20,320 | 18,159 | - | - | ||
Other expenses, net | ||||||
12,169 | 6,061 | 7,581 | - | - | ||
Restructuring income | ||||||
0 | 40,300 | 0 | - | - | ||
Restructuring expenses | ||||||
3,628 | 15,620 | 6,492 | - | - | ||
Income from operations | ||||||
147,151 | 196,305 | 137,871 | - | - | ||
Interest and other financial expense, net | ||||||
27,572 | 28,642 | 44,135 | - | - | ||
Reclassification of actuarial losses from AOCI | ||||||
0 | 0 | -9,687 | - | - | ||
Income from operations before income taxes and equity in earnings of affiliated companies | ||||||
119,579 | 167,663 | 84,049 | - | - | ||
Income tax expense | ||||||
33,216 | 46,944 | 19,736 | - | - | ||
Equity in earnings of affiliated companies, net of tax | ||||||
558 | 591 | 547 | - | - | ||
Net income | ||||||
86,920 | 121,310 | 64,860 | - | - | ||
Weighted-average shares outstanding (in thousands of shares): | ||||||
Basic (in shares) | ||||||
59,986 | 59,567 | 59,320 | - | - | ||
Diluted (in shares) | ||||||
61,300 | 61,049 | 60,674 | - | - | ||
Earnings per share: | ||||||
Basic (in USD per share) | ||||||
1.45 | 2.04 | 1.09 | - | - | ||
Diluted (in USD per share) | ||||||
1.42 | 1.99 | 1.07 | - | - | ||
Dividends per share (in USD per share) | ||||||
0.80 | 0.80 | 0.77 | - | - | ||
Weighted average number of ordinary shares, basic (in thousand of shares) | ||||||
- | - | - | 59,353 | 59,635 | ||
Weighted average number of ordinary shares, diluted (in thousand of shares) | ||||||
- | - | - | 60,154 | 59,830 | ||